Skip to main content
IBRN logo
IBRN
(NYSEARCA)
iShares Neuroscience and Healthcare ETF
$34.15-- (--)
Loading... - Market loading

IBRN ETF: iShares Neuroscience and Healthcare ETF - Price, Holdings & Analysis

iShares Neuroscience and Healthcare ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$34.83 - $35.17
52-Week High$37.00
52-Week Low$21.78
Open$34.83
Volume1.00K
Average Volume (3M)1.30K
Assets (AUM)5.18M
Expense Ratio0.47%
Total Holdings84
Inception DateAug 23, 2022
1 Day Change1.56%
1 Month Change-1.78%
6 Month Change7.42%
YTD Change8.03%
1 Year Change48.85%
52-Week Change50.58%
50-Day MA$34.33
200-Day MA$30.99
RSI46.34
Stochastic %K37.45
Stochastic %D42.80
Annual Dividend$0.32
Dividend Yield0.93%
Last Dividend Ex-DateDec 19, 2026
Dividend Growth YoY216.83%
Years Dividend Growth2

Frequently Asked Questions About iShares Neuroscience and Healthcare ETF

What is the current price of IBRN?

The latest IBRN price is $34.93. The 52-week range is $21.78–$37.00. IBRN has returned 50.6% over the past 52 weeks.

What is the expense ratio for IBRN?

IBRN's annual expense ratio is 0.47%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does IBRN pay dividends?

Yes, IBRN pays a 0.93% dividend yield. The last ex-dividend date was 2026-12-19. View full dividend history in the Dividends section.

What are the top holdings of IBRN?

IBRN's largest holdings are Xenon Pharmaceuticals Inc (4.9%), Arrowhead Pharmaceuticals, Inc. (4.4%), Alkermes plc (4.2%) (combined weight: 13.5%). The fund holds 84 total positions. View the complete portfolio breakdown in the Holdings section.

How does IBRN compare to similar ETFs?

Compare IBRN (0.47% expense ratio, $5M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.